モノクローナル抗体の世界市場：パイプラインインサイト...市場調査レポートについてご紹介

1. Introduction to Monoclonal Antibodies

2. Monoclonal Antibodies Classification
2.1 Naked Monoclonal Antibodies
2.2 Conjugated Monoclonal Antibodies
2.2.1 Radiolabeled Antibodies
2.2.2 Chemolabeled Antibodies
2.2.3 Immunotoxins

3. Mechanism of Monoclonal Antibodies
3.1 Generation of Hybridomas
3.1.1 In Vitro Production of Monoclonal Antibodies
3.1.2 Batch Tissue Culture Methods
3.1.3 Semipermeable Membrane Based Systems
3.1.4 Advantages & Disadvantages of In Vitro and In Vivo Methods
3.2 Working of Monoclonal Antibodies

4. Need for Monoclonal Antibodies

5. Emerging Area: Cancer Monoclonal Antibodies Therapy

6. Global Monoclonal Antibodies Market Overview
6.1 Current Market Scenario
6.2 Monoclonal Antibodies Pipeline Insight
6.3 Cancer Monoclonal Antibodies Clinical Pipeline Insight

7. Monoclonal Antibodies Market Dynamics
7.1 Favorable Market Parameters
7.2 Development & Commercialization Challenges

8. Global Monoclonal Antibodies Market Future Outlook

9. Monoclonal Antibodies Clinical Pipeline by Company, Indication & Phase
9.1 Unknown
9.2 Research
9.3 Preclinical
9.4 Clinical
9.5 Phase-0
9.6 Phase-I
9.7 Phase-I/II
9.8 Phase-II
9.9 Phase-II/III
9.10 Phase-III
9.11 Preregistration
9.12 Registered

10. Marketed Monoclonal Antibodies by Company & Indication

11. Competitive Landscape
11.1 Abbvie
11.2 Amgen
11.3 Bayer HealthCare
11.4 Biogen Idec
11.5 Eli Lilly
11.6 Genmab
11.7 Gilead Sciences
11.8 GlaxoSmithKline
11.9 Novartis
11.10 Pfizer
11.11 Roche
11.12 Seattle Genetics